摘要
目的探讨盐酸氟桂利嗪治疗脑动脉硬化症的临床疗效及安全性。方法将我院2010—2012年收治的110例脑动脉硬化症患者随机分为观察组和对照组,各55例,对照组患者给予常规治疗,观察组患者在常规基础上给予盐酸氟桂利嗪治疗,比较两组患者的临床疗效,记录不良反应情况。结果观察组患者治疗总有效率为92.7%,高于对照组的76.4%,差异有统计学意义(P<0.05)。对照组患者治疗过程中未出现明显不良反应,观察组患者中2例出现头晕,1例出现嗜睡、乏力,停药后症状自行缓解。结论应用盐酸氟桂利嗪治疗脑动脉硬化症临床疗效好,且不良反应少,症状较为轻微,临床应用安全性较高,值得临床广泛推广使用。
Objective To investigate the clinical efficacy and safety of Flunarizine Hydrochloride in the treatment of cerebral arteriosclerosis.Methods 110 cases of cerebral arteriosclerosis in our hospital from 2010 to 2012 years were divided into observation group and control group,55 cases in each group,cases in the control group were given routine treatment,based on this,patients in the observation group were given flunarizine hydrochloride treatment,compared the clinical efficacy of patients in two groups,recorded the adverse reaction.Results The total effective rate in the observation group was 92.7%,significantly higher than that in control group（76.4%）,there was significant difference（P0.05）.There was no serious adverse reaction of patients in the control group in treatment,patients in the observation group 2 cases occurred dizziness,1 case occurred drowsiness and fatigue,the symptoms relieved after stopping drug.Conclusion Taking flunarizine hydrochloride in the treatment of cerebral arteriosclerosis has good clinical efficacy,and has less adverse reaction,the symptom is slight,has high security in clinical application,so it is worthy of further clinical using.
出处
《实用心脑肺血管病杂志》
2013年第6期84-85,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
脑动脉硬化症
盐酸氟桂利嗪
治疗结果
Intracranial arteriosclerosis
Flunarizine
Treatment outcome
